Essential Amino Acid Supplementation for femoral fractures

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Sep 2023: Trial registered, NCT06050668
  2. 17 Jun 2024: Trial started, NCT06050668

The trials

NCT06050668: Essential Amino Acid Supplementation for Femoral Fragility Fractures

State
Under way
Phase
Phase 2
People
60 planned
Started
17 Jun 2024
Primary completion
Dec 2026
Arms
Essential Amino Acid Supplementation
Results
None posted
  1. 22 Sep 2023: Trial registered
  2. 17 Jun 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.